abstract |
The object of the present invention is to provide a monoclonal antibody that binds to human XCR1, wherein the antibody binds to a linear epitope or a non-contiguous epitope comprising at least three amino acids selected from the group consisting of: SEQ ID NO: 8, 8, 11, 12, 14, 16, 17, 22, 23, 176, and 177 amino acids in the amino acid sequence of 91. |